[PDF][PDF] Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine
academia.edu
* The derived vaccine efficacies were calculated as 100×(1−[risk among vaccinated
patients/risk among unvaccinated patients]), on the basis of those remaining at risk …
patients/risk among unvaccinated patients]), on the basis of those remaining at risk …
[PDF][PDF] Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
DM Skowronski, MD Gaston De Serres - 2021 - arcturusrx.com
To the Editor: Polack et al.(Dec. 31) 1 report a vaccine efficacy of 94.8% against Covid-19
after two doses of the messenger RNA (mRNA) vaccine BNT162b2 (Pfizer–BioNTech). The …
after two doses of the messenger RNA (mRNA) vaccine BNT162b2 (Pfizer–BioNTech). The …
[引用][C] Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
DM Skowronski, G De Serres… - New England Journal of …, 2021 - hal.science
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine - Archive ouverte HAL Accéder
directement au contenu Documentation FR Français (FR) Anglais (EN) Se connecter HAL …
directement au contenu Documentation FR Français (FR) Anglais (EN) Se connecter HAL …
[引用][C] Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
X Wang - The New England Journal of Medicine, 2021 - europepmc.org
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. - Abstract - Europe PMC Sign in
| Create an account https://orcid.org Europe PMC Menu About Tools Developers Help Contact …
| Create an account https://orcid.org Europe PMC Menu About Tools Developers Help Contact …
[PDF][PDF] Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
TW Wang, AS Gentzke, E Park-Lee - Morb Mortal Wkly Rep, 2020 - academia.edu
* The derived vaccine efficacies were calculated as 100×(1−[risk among vaccinated
patients/risk among unvaccinated patients]), on the basis of those remaining at risk …
patients/risk among unvaccinated patients]), on the basis of those remaining at risk …
[引用][C] Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
JN Vergnes - The New England journal of medicine, 2021 - pubmed.ncbi.nlm.nih.gov
[PDF][PDF] Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
DM Skowronski, MD Gaston De Serres - 2021 - arcturusrx.com
To the Editor: Polack et al.(Dec. 31) 1 report a vaccine efficacy of 94.8% against Covid-19
after two doses of the messenger RNA (mRNA) vaccine BNT162b2 (Pfizer–BioNTech). The …
after two doses of the messenger RNA (mRNA) vaccine BNT162b2 (Pfizer–BioNTech). The …
[引用][C] Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
DM Skowronski, G De Serres - The New England …, 2021 - pubmed.ncbi.nlm.nih.gov
[引用][C] Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
JN Vergnes - The New England Journal of Medicine, 2021 - europepmc.org
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. - Abstract - Europe PMC Sign
in | Create an account https://orcid.org Europe PMC Menu About Tools Developers Help …
in | Create an account https://orcid.org Europe PMC Menu About Tools Developers Help …